Lea L. Friker
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypes.
Journal: Journal of neuro-oncology
Published: March 27, 2026
Needle-track metastasis in diffuse intrinsic pontine glioma: Need for a standardized surgical strategy?
Journal: Neuro-oncology advances
Published: February 12, 2026
Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study.
Journal: Clinical and translational radiation oncology
Published: July 20, 2025
Core2Edge: a human glioblastoma organoid-brain slice model capturing infiltration and transcriptional heterogeneity from core to single-cell dispersion.
Journal: Nature protocols
Published: July 19, 2025
Intraoperative radiotherapy for resectable brain metastases: a systematic review and meta-analysis.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 07, 2025
Haematotoxicity of Craniospinal Radiochemotherapy for Metastatic Paediatric High-Grade Glioma.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: June 25, 2025
Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group.
Journal: Neuro-oncology practice
Published: May 28, 2025
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.
Journal: Nature communications
Published: May 01, 2025
Histological and molecular characterization of endolymphatic sac tumor reveals key differences from its primary differential diagnosis, choroid plexus papilloma.
Journal: Histology and histopathology
Published: April 29, 2025
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma.
Journal: Neuro-oncology
Published: March 26, 2025
Pitfalls in the evaluation of CDKN2A copy number status in meningioma.
Journal: Journal of neuro-oncology
Published: February 03, 2025
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma.
Journal: Acta neuropathologica
Published: November 13, 2024
Last Updated: 09/26/2026